Raltegravir
ATC Code
J05AJ01
Raltegravir
Definition
A small molecule with activity against human immunodeficiency virus (HIV). Raltegravir is an integrase inhibitor that blocks the integration of the viral genome into the host DNA, a critical step in the pathogenesis of HIV.
Also known as MK-0518, N-(2-(4-(4-Fluorobenzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide, RALTEGRAVIR — per NCIT
Also identified as
- ATC J05AJ01 per RXNORM
- NCIT NCIT:C72837 per NCIT
- SCTID 429368003 per RXNORM
- SCTID 429707008 per RXNORM
- UNII 22VKV8053U per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| HIV infectious disease | may treat | MEDRT · Public domain (U.S. Government work) |